Showing results (51-60 of 137) with videos related to
Sort By:
Pageof 14
Journal of Clinical Lipidology|October 22, 2025
Noninvasive indices of hepatic steatosis and fibrosis for the prediction of obstructive coronary artery diseaseDimitrios Trygoniaris, Nikolaos Mittas, Andreas S Papazoglou, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|March 6, 2008
Correlation of near infrared absorption and diffuse reflectance spectroscopy scattering with tissue neovascularization and collagen concentration in a diabetic rat wound healing modelMichael S Weingarten, Elisabeth S Papazoglou, Leonid Zubkov, et al.Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 26, 2022
Nanotherapy based on magneto-mechanochemical modulation of tumor redox stateValerii B Orel, Αndreas S Papazoglou, Christos Tsagkaris, et al.Journal of Clinical Medicine|October 14, 2022
Sex-Related Differences in Clinical Outcomes in Patients with Atrial Fibrillation and Coronary Artery Disease: A Sub-Study of the MISOAC-AF Randomized Controlled TrialAlexandra Bekiaridou, Athanasios Samaras, Anastasios Kartas, et al.Journal of Cardiology|September 30, 2022
Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trialVasiliki Patsiou, Athanasios Samaras, Anastasios Kartas, et al.British Journal of Rheumatology|October 23, 1998
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety AssessmentC Hawkey, A Kahan, K Steinbrück, et al.Heart Failure Reviews|June 12, 2023
The prognostic value of right ventricular longitudinal strain in heart failure: a systematic review and meta-analysisVasileios Anastasiou, Andreas S Papazoglou, Dimitrios V Moysidis, et al.Journal of Cardiovascular Development and Disease|March 26, 2025
Oral Anticoagulation Choice and Dosage in Very Elderly Patients with Atrial FibrillationMartha Zergioti, Melina Kyriakou, Andreas S Papazoglou, et al.British Journal of Rheumatology|October 23, 1998
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritisJ Dequeker, C Hawkey, A Kahan, et al.Cardiovascular Diabetology|March 15, 2022
Glycemic control and atrial fibrillation: an intricate relationship, yet under investigationAndreas S Papazoglou, Anastasios Kartas, Dimitrios V Moysidis, et al.Pageof 14